Th1/M1 conversion to Th2/M2 responses in models of inflammation lacking cell death stimulates maturation of monocyte precursors to fibroblasts

Frontiers in Immunology

Volumn 4, Issue SEP, 2013, Pages

  Trial, JoAnn ^a,b   Cieslik, Katarzyna A ^a,b   Haudek, Sandra B ^a,b   Duerrschmid, Clemens ^a,b   Entman, Mark L ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

Fibrosis; IL 13; IL 33; M1; M2; MCP 1; Monocytes

Indexed keywords

CD34 ANTIGEN; CD45 ANTIGEN; INTERLEUKIN 13; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MATURATION; CELL MIGRATION ASSAY; CONTROLLED STUDY; FIBROBLAST; FLOW CYTOMETRY; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MACROPHAGE; MOUSE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN MICROARRAY; RNA ISOLATION; TH1 CELL; TH2 CELL; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

EID: 84886054689     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00287     Document Type: Article

References (51)

1. Stoecklein VM, Osuka A, Lederer JA. Trauma equals danger-damage control by the immune system. J Leukoc Biol (2012) 92(3):539-51. doi:10.1189/jlb.0212072.
2. Mathur S, Walley KR, Wang Y, Indrambarya T, Boyd JH. Extracellular heat shock protein 70 induces cardiomyocyte inflammation and contractile dysfunction via TLR2. Circ J (2011) 75(10):2445-52. doi:10.1253/circj. CJ-11-0194.
3. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature (2010) 464(7285):104-7. doi:10.1038/nature08780.
4. Andersson U, Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol (2011) 29:139-62. doi:10.1146/annurev-immunol-030409-101323.
5. Yang D, Chen Q, Yang H, Tracey KJ, Bustin M, Oppenheim JJ. High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol (2007) 81(1):59-66. doi:10.1189/jlb.0306180.
6. Oppenheim JJ, Yang D. Alarmins: chemotactic activators of immune responses. Curr Opin Immunol (2005) 17(4):359-65. doi:10.1016/j.coi.2005.06.002.
7. Zhang N, Yang D, Dong H, Chen Q, Dimitrova DI, Rogers TJ, et al. Adenosine A2a receptors induce heterologous desensitization of chemokine receptors. Blood (2006) 108(1):38-44. doi:10.1182/blood-2005-06-2599.
8. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest (1998) 101(4):890-8. doi:10.1172/JCI1112.
9. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature (1997) 390(6658):350-1. doi:10.1038/37022.
10. Seledtsov VI, Seledtsova GV. A balance between tissue-destructive and tissue-protective immunities: a role of toll-like receptors in regulation of adaptive immunity. Immunobiology (2012) 217(4):430-5. doi:10.1016/j.imbio.2011.10.011.
11. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol (2004) 25(12):677-86. doi:10.1016/j.it.2004.09.015.
12. Dewald O, Frangogiannis NG, Zoerlein M, Duerr GD, Klemm C, Knuefermann P, et al. Development of murine ischemic cardiomyopathy is associated with a transient inflammatory reaction and depends on reactive oxygen species. Proc Natl Acad Sci U S A (2003) 100:2700-5. doi:10.1073/pnas.0438035100.
13. Haudek SB, Xia Y, Huebener P, Lee JM, Carlson S, Crawford JR, et al. Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc Natl Acad Sci U S A (2006) 103(48):18284-9. doi:10.1073/pnas.0608799103.
14. Crawford JR, Haudek SB, Cieslik KA, Trial J, Entman ML. Origin of developmental precursors dictates the pathophysiologic role of cardiac fibroblasts. J Cardiovasc Transl Res (2012) 5(6):749-59. doi:10.1007/s12265-012-9402-7.
15. Frangogiannis NG, Dewald O, Xia Y, Ren G, Haudek S, Leucker T, et al. Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy. Circulation (2007) 115(5):584-92. doi:10.1161/CIRCULATIONAHA.106.646091.
16. Haudek SB, Cheng J, Du J, Wang Y, Hermosillo-Rodriguez J, Trial J, et al. Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy. J Mol Cell Cardiol (2010) 49(3):499-507. doi:10.1016/j.yjmcc.2010.05.005.
17. Haudek SB, Trial J, Xia Y, Gupta D, Pilling D, Entman ML. Fc receptor engagement mediates differentiation of cardiac fibroblast precursor cells. Proc Natl Acad Sci U S A (2008) 105(29):10179-84. doi:10.1073/pnas.0804910105.
18. Duerrschmid C, Crawford JR, Reineke E, Taffet GE, Trial J, Entman ML, et al. TNF receptor 1 signaling is critically involved in mediating angiotensin-II-induced cardiac fibrosis. J Mol Cell Cardiol (2013) 57:59-67. doi:10.1016/j.yjmcc.2013.01.006.
19. Haudek SB, Gupta D, Dewald O, Schwartz RJ, Wei L, Trial J, et al. Rho kinase-1 mediates cardiac fibrosis by regulating fibroblast precursor cell differentiation. Cardiovasc Res (2009) 83(3):511-8. doi:10.1093/cvr/cvp135.
20. Ancuta P, Rao R, Moses A, Mehle A, Shaw SK, Luscinskas FW, et al. Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J Exp Med (2003) 197(12):1701-7. doi:10.1084/jem.20022156.
21. Cieslik KA, Taffet GE, Carlson S, Hermosillo J, Trial J, Entman ML. Immune-inflammatory dysregulation modulates the incidence of progressive fibrosis and diastolic stiffness in the aging heart. J Mol Cell Cardiol (2011) 50(1):248-56. doi:10.1016/j.yjmcc.2010.10.019.
22. Kaviratne M, Hesse M, Leusink M, Cheever AW, Davies SJ, McKerrow JH, et al. IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent. J Immunol (2004) 173(6):4020-9.
23. Lee CG, Homer RJ, Zhu Z, Lanone S, Wang X, Koteliansky V, et al. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med (2001) 194(6):809-21. doi:10.1084/jem.194.6.809.
24. Westcott DJ, Delproposto JB, Geletka LM, Wang T, Singer K, Saltiel AR, et al. MGL1 promotes adipose tissue inflammation and insulin resistance by regulating 7/4hi monocytes in obesity. J Exp Med (2009) 206(13):3143-56. doi:10.1084/jem.20091333.
25. Feinberg MW, Cao Z, Wara AK, Lebedeva MA, Senbanerjee S, Jain MK. Kruppel-like factor 4 is a mediator of proinflammatory signaling in macrophages. J Biol Chem (2005) 280(46):38247-58. doi:10.1074/jbc. M509378200.
26. Whyte CS, Bishop ET, Ruckerl D, Gaspar-Pereira S, Barker RN, Allen JE, et al. Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function. J Leukoc Biol (2011) 90(5):845-54. doi:10.1189/jlb.1110644.
27. Entman ML, Cieslik KA, Carlson S, Haudek SB, Trial J. Myeloid fibroblast precursors in cardiac interstitial fibrosis-the origin of fibroblast precursors dictate the pathophysiologic role. In: Bucala R, editor. Fibrocytes in Health and Disease. Hackensack, NJ: World Scientific Press (2011). p. 197-228.
28. Guo L, Wei G, Zhu J, Liao W, Leonard WJ, Zhao K, et al. IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. Proc Natl Acad Sci U S A (2009) 106(32):13463-8. doi:10.1073/pnas.0906988106.
29. Kondo Y, Yoshimoto T, Yasuda K, Futatsugi-Yumikura S, Morimoto M, Hayashi N, et al. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int Immunol (2008) 20(6):791-800. doi:10.1093/intimm/dxn037.
30. Fichtner-Feigl S, Strober W, Kawakami K, Puri RK, Kitani A. IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat Med (2006) 12(1):99-106. doi:10.1038/nm1332.
31. Fuschiotti P, Medsger TA Jr, Morel PA. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis. Arthritis Rheum (2009) 60(4):1119-28. doi:10.1002/art.24432.
32. Kakkar R, Hei H, Dobner S, Lee RT. Interleukin 33 as a mechanically responsive cytokine secreted by living cells. J Biol Chem (2012) 287(9):6941-8. doi:10.1074/jbc. M111.298703.
33. Moussion C, Ortega N, Girard JP. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS One (2008) 3(10):e3331. doi:10.1371/journal.pone.0003331.
34. Roca H, Varsos ZS, Sud S, Craig MJ, Ying C, Pienta KJ. CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization. J Biol Chem (2009) 284(49):34342-54. doi:10.1074/jbc. M109.042671.
35. Karpus WJ, Lukacs NW, Kennedy KJ, Smith WS, Hurst SD, Barrett TA. Differential CC chemokine-induced enhancement of T helper cell cytokine production. J Immunol (1997) 158(9):4129-36.
36. Lehmann I, Roder-Stolinski C, Nieber K, Fischader G. In vitro models for the assessment of inflammatory and immuno-modulatory effects of the volatile organic compound chlorobenzene. Exp Toxicol Pathol (2008) 60(2-3):185-93. doi:10.1016/j.etp.2008.01.009.
37. Gu L, Tseng S, Horner RM, Tam C, Loda M, Rollins BJ. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature (2000) 404(6776):407-11. doi:10.1038/35006097.
38. Jura J, Skalniak L, Koj A. Monocyte chemotactic protein-1-induced protein-1 (MCPIP1) is a novel multifunctional modulator of inflammatory reactions. Biochim Biophys Acta (2012) 1823(10):1905-13. doi:10.1016/j.bbamcr.2012.06.029.
39. Xu J, Fu S, Peng W, Rao Z. MCP-1-induced protein-1, an immune regulator. Protein Cell (2012) 3(12):903-10. doi:10.1007/s13238-012-2075-9.
40. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL, et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med (2007) 204(12):3037-47. doi:10.1084/jem.20070885.
41. Tsujioka H, Imanishi T, Ikejima H, Kuroi A, Takarada S, Tanimoto T, et al. Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction. J Am Coll Cardiol (2009) 54(2):130-8. doi:10.1016/j.jacc.2009.04.021.
42. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol (2011) 11(11):723-37. doi:10.1038/nri3073.
43. Murray LA, Argentieri RL, Farrell FX, Bracht M, Sheng H, Whitaker B, et al. Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2. Int J Biochem Cell Biol (2008) 40(10):2174-82. doi:10.1016/j.biocel.2008.02.016.
44. Guo L, Junttila IS, Paul WE. Cytokine-induced cytokine production by conventional and innate lymphoid cells. Trends Immunol (2012) 33(12):598-606. doi:10.1016/j.it.2012.07.006.
45. Chizzolini C, Brembilla NC, Montanari E, Truchetet ME. Fibrosis and immune dysregulation in systemic sclerosis. Autoimmun Rev (2011) 10(5):276-81. doi:10.1016/j.autrev.2010.09.016.
46. Kanzler I, Liehn EA, Koenen RR, Weber C. Anti-inflammatory therapeutic approaches to reduce acute atherosclerotic complications. Curr Pharm Biotechnol (2012) 13(1):37-45. doi:10.2174/138920112798868557.
47. Huang S, Miao R, Zhou Z, Wang T, Liu J, Liu G, et al. MCPIP1 negatively regulates toll-like receptor 4 signaling and protects mice from LPS-induced septic shock. Cell Signal (2013) 25(5):1228-34. doi:10.1016/j.cellsig.2013.02.009.
48. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med (1994) 1(1):71-81.
49. Pilling D, Buckley CD, Salmon M, Gomer RH. Inhibition of fibrocyte differentiation by serum amyloid P. J Immunol (2003) 171(10):5537-46.
50. Bruckner BA, Stetson SJ, Farmer JA, Radovancevic B, Frazier OH, Noon GP, et al. The implications for cardiac recovery of left ventricular assist device support on myocardial collagen content. Am J Surg (2000) 180(6):498-501. doi:10.1016/S0002-9610(00)00553-5.
51. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem (2009) 55:611-22. doi:10.1373/clinchem.2008.112797.